CLEVELAND — As a panel on Wednesday, the final day of the Cleveland Clinic Medical Innovation Summit, discussed ways healthcare reform will change life for medical innovators, an interesting theme emerged: Innovation is not at the healthcare reform table. (Medical Device Daily)

CLEVELAND — As has become a tradition at the Cleveland Clinic Medical Innovation Summit, a panel of Cleveland Clinic practitioners on Wednesday unveiled the clinic's fourth annual much-anticipated Top 10 list of medical innovations expected to have a big impact on healthcare in 2010. (Medical Device Daily)

CLEVELAND — At a time when money is difficult to come by all around, the organizers of this year's Cleveland Clinic Medical Innovation Summit recognized that attendees might find it interesting to learn how large corporations are increasing their activity as it relates to venture investing. (Medical Device Daily)

CLEVELAND — In a time of continuous heated debates about reforming America's healthcare system, the CEO of IBM, Sam Palmisano, spoke to attendees at the Cleveland Clinic Medical Innovation Summit on Tuesday about why the U.S. healthcare system isn't a "system" at all. (Medical Device Daily)

CLEVELAND – With many of the nearly 1,000 attendees at the 7th annual Cleveland Clinic Medical Innovation Summit walking around the InterContinental Hotel and Conference Center this week toting black bags with the words: "Cancer Cures Through Innovation" boldly printed in white, it's not difficult to pick up on this year's clinical theme. (Medical Device Daily)

The 7th annual Cleveland Clinic Medical Innovation Summit which begins today, will have "all the ingredients" for a truly unique gathering, Chris Coburn told Medical Device Daily. (Medical Device Daily)

CVRx (Minneapolis) reported the first enrollment of a patient in the HOPE4HF trial, a study that is evaluating the company's Rheos System to treat heart failure. The implantable device is already approved for treating hypertension patients in Europe. (Medical Device Daily)

Sanuwave (Alpharetta, Georgia), a company developing non-invasive, biological response activating devices in the regenerative medicine area, reported that it has become the subsidiary of a publicly traded company through a reverse merger agreement with a subsidiary of Rub Music Enterprises (RME). Sanuwave is the surviving entity in the reverse merger, which became effective on Friday. (Medical Device Daily)